Purchase Order 75D30123P16506

Award Date 6/15/23
Potential Completion Date 6/14/28
Potential Value $161K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Abbott Laboratories
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, for the ABBOTT-ALINITY MNAT PLATFORM. The $353,318.00 contract has a completion date of November 5, 2022. Abbott Molecular, a for-profit manufacturer, has a history of providing molecular diagnostic products and services to federal agencies including the Department of Veterans Affairs, CDC, and Department...
This firm-fixed-price purchase order was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, for an estimated $100,800.00. The contract does not have a set-aside designation. Abbott Molecular, a manufacturer of molecular diagnostic products and services, will provide unspecified "other functions" to support the CDC's operations in Atlanta, Georgia. The award is not...
This federal contract award is to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, to provide a range of molecular diagnostics equipment, reagents, and testing services to the Department of Health and Human Services Centers for Disease Control and Prevention (CDC). The contract has a potential value of $145,589.00 and is a Delivery Order under the Critical Analyzers, Laboratory GSA Schedule contract. The contract does not have a set-aside designation. Through this award, Abbott...
This firm-fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, for the provision of reagents and kits for the ABBO. The contract has a ceiling value of $43,917.84 and a period of performance through August 15, 2024. This award is not associated with a set-aside program. Abbott Molecular is a global manufacturer of molecular diagnostic products and services, including COVID-19 test kits,...
This federal contract award is for the provision of reagents and consumables for use on the Abbott M2000SP and Abbott M2000RT molecular diagnostic platforms. The $121,338.60 contract was awarded to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, by the Department of Health and Human Services Centers for Disease Control and Prevention. The contract is a Blanket Purchase Agreement (BPA) call order under the GSA Schedule for In Vitro Diagnostics, Reagents, and Test (FSS-65-VII). No...
This federal contract award, valued at $718,564.83, was made by the Veterans Integrated Service Network 1 (VISN 1), a division of the U.S. Department of Veterans Affairs (VA), to Abbott Molecular Inc., a subsidiary of Abbott Laboratories. The contract is a Blanket Purchase Agreement (BPA) call for the provision of Alinity M COVID-19 testing, HIV testing, and human papillomavirus (HPV) testing supplies. The contract has a firm fixed price pricing type and a completion date of September 21,...
This is a federal contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Abbott Molecular Inc., a subsidiary of Abbott Laboratories. The contract is for the delivery of laboratory supplies, with a potential value of $134,274.88. The contract was issued as a Delivery Order under the GSA Schedule 65-VII contract for Invitro Diagnostics, Reagents, and Test. The contract does not have a set-aside designation. Abbott Molecular is a...
This federal contract award was issued by the Department of Veterans Affairs (VA) to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, a global healthcare company. The contract has an award value of $507,223.63 and is an Indefinite Delivery/Indefinite Quantity (IDIQ) contract for the procurement of Alinity reagents and supplies. The contract has a performance period through September 30, 2024 and utilizes a Firm Fixed Price pricing structure. This contract is not set aside for any...
This is a federal contract award to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, by the Centers for Disease Control and Prevention (CDC) Pittsburgh office. The contract is for the delivery of reagent kits, with a ceiling value of $87,060.00. It was awarded under the General Services Administration (GSA) Federal Supply Schedule (FSS) contract for Critical Analyzers, Laboratory (FSS-66-III), using a Firm Fixed Price pricing type. The contract has a performance period ending on...
This federal contract award is for the purchase of ALINITY M diagnostic systems and related services from Abbott Molecular Inc., a subsidiary of Abbott Laboratories. The $326,800 firm fixed price contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration under a purchase order. The contract has a period of performance through September 30, 2021 and was not set aside for any particular business type. Abbott Molecular is a manufacturer of molecular diagnostic...

This federal contract award is for a yearly service agreement between the Centers for Disease Control and Prevention (CDC) and Abbott Molecular Inc., a subsidiary of Abbott Laboratories, for the Abbott Alinity M NAT System. The $160,552.75 firm fixed-price purchase order does not have a set-aside designation, reflecting Abbott's status as a large, established medical technology corporation. The contract has an ultimate completion date of June 14, 2028. Abbott Molecular Inc. is the prime contractor and is providing critical molecular diagnostic equipment, reagents, and testing services to support federal healthcare testing capabilities, particularly during the COVID-19 pandemic. This contract is part of Abbott Molecular's broader federal contract portfolio, which includes multiple Indefinite Delivery Vehicles (IDVs) across agencies like the Department of Veterans Affairs and the Department of Defense, focused on supplying a range of medical diagnostic products and services.

Generated 6/6/25, 9:44 AM